These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15897779)

  • 1. Negative metabolic effects of cGMP are enhanced in obese rat hearts.
    Weiss HR; Katz E; Tse J; Scholz PM
    J Cardiovasc Pharmacol; 2005 Jun; 45(6):533-8. PubMed ID: 15897779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative metabolic and coronary flow effects of decreases in cAMP and increases in cGMP in control and renal hypertensive rabbit hearts.
    Rodriguez R; Molino B; Weiss HR; Scholz PM
    J Appl Physiol (1985); 2004 Jul; 97(1):439-45. PubMed ID: 14990553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increases in myocardial cyclic GMP attenuate contractile delay in myocardial stunning.
    Huang MW; Scholz PM; Weiss HR
    Can J Physiol Pharmacol; 2002 Aug; 80(8):804-10. PubMed ID: 12269791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in nitric oxide-cGMP pathway in ventricular myocytes from obese leptin-deficient mice.
    Su J; Zhang S; Tse J; Scholz PM; Weiss HR
    Am J Physiol Heart Circ Physiol; 2003 Nov; 285(5):H2111-7. PubMed ID: 12869380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between cGMP and myocardial O2 consumption is altered in T4-induced cardiac hypertrophy.
    Weiss HR; Rodriguez E; Tse J
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H686-91. PubMed ID: 7864195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ageing blunts the effects of nitric oxide on myocardial O2 consumption.
    Weiss HR; Lazar MJ; Tse J; Scholz PM
    Clin Exp Pharmacol Physiol; 2002 Oct; 29(10):924-30. PubMed ID: 12207573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered relationship between cyclic GMP and myocardial O2 consumption in renal hypertension-induced cardiac hypertrophy.
    Rabindranauth P; Scholz PM; Tse J; Naim KL; Weiss HR
    Res Exp Med (Berl); 1998 Jul; 198(1):11-21. PubMed ID: 9706666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II type 2 receptor agonist directly inhibits proximal tubule sodium pump activity in obese but not in lean Zucker rats.
    Hakam AC; Hussain T
    Hypertension; 2006 Jun; 47(6):1117-24. PubMed ID: 16618840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered effects of acetylcholine on cyclic AMP and GMP induced changes in O2 consumption of hypertrophic dog cardiac myocytes.
    Gong GX; Straznicka M; Weiss HR; Tse J; Scholz PM
    J Auton Pharmacol; 1999 Feb; 19(1):19-28. PubMed ID: 10385266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced myocardial cyclic GMP increases myocardial O2 consumption in control but not renal hypertension-induced cardiac hypertrophy.
    Sadoff JD; Scholz PM; Tse J; Weiss HR
    Cardiovasc Res; 1997 Dec; 36(3):453-9. PubMed ID: 9534866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative metabolic effects of cyclic GMP are altered in renal hypertension induced cardiac hypertrophy.
    Rabindranauth P; Naim KL; Scholz PM; Tse J; Sadoff JD; Weiss HR
    Basic Res Cardiol; 1997 Feb; 92(1):8-16. PubMed ID: 9062647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic GMP reduces myocardial stunning through non-cyclic GMP protein kinase mechanisms.
    Zhang Q; Lazar M; Yan L; He Y; Tse J; Weiss HR; Scholz PM
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):235-43. PubMed ID: 15243306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic GMP reduces ventricular myocyte stunning after simulated ischemia-reperfusion.
    Gandhi A; Yan L; Scholz PM; Huang MW; Weiss HR
    Nitric Oxide; 1999 Dec; 3(6):473-80. PubMed ID: 10637126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases.
    Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM
    Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NG-methyl-L-arginine decreases contractility, cGMP and cAMP in isoproterenol-stimulated rat hearts in vitro.
    Klabunde RE; Kimber ND; Kuk JE; Helgren MC; Förstermann U
    Eur J Pharmacol; 1992 Nov; 223(1):1-7. PubMed ID: 1335873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for altered sensitivity of the nitric oxide/cGMP signalling cascade in insulin-resistant skeletal muscle.
    Young ME; Leighton B
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):73-9. PubMed ID: 9405277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac β-adrenergic responsiveness of obese Zucker rats: The role of AMPK.
    Bussey CT; Thaung HPA; Hughes G; Bahn A; Lamberts RR
    Exp Physiol; 2018 Aug; 103(8):1067-1075. PubMed ID: 29873129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic GMP attenuates cyclic AMP-stimulated inotropy and oxygen consumption in control and hypertrophic hearts.
    Leone RJ; Straznicka M; Scholz PM; Weiss HR
    Basic Res Cardiol; 2000 Feb; 95(1):28-38. PubMed ID: 10752543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats.
    De Gennaro-Colonna V; Rossoni G; Cocchi D; Rigamonti AE; Berti F; Muller EE
    J Endocrinol; 2000 Sep; 166(3):529-36. PubMed ID: 10974647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive functional effects of milrinone and methylene blue are not additive in control and hypertrophic canine hearts.
    Leone RJ; Weiss HR; Scholz PM
    J Surg Res; 1998 Jun; 77(1):23-8. PubMed ID: 9698527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.